TY  - GEN
AU  - Ray,Jessica
AU  - Haughey,Charles
AU  - Hoey,Christianne
AU  - Jeon,Jouhyun
AU  - Murphy,Ross
AU  - Dura-Perez,Lara
AU  - McCabe,Nuala
AU  - Downes,Michelle
AU  - Jain,Suneil
AU  - Boutros,Paul C
AU  - Mills,Ian G
AU  - Liu,Stanley K
TI  - miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA
SN  - 1872-7980
PY  - 2020///1005
KW  - Alitretinoin
KW  - administration & dosage
KW  - Animals
KW  - Antineoplastic Agents
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Cell Line, Tumor
KW  - Chemoradiotherapy, Adjuvant
KW  - methods
KW  - Disease-Free Survival
KW  - Down-Regulation
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Gene Knockdown Techniques
KW  - Humans
KW  - Kallikreins
KW  - blood
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Mice
KW  - MicroRNAs
KW  - agonists
KW  - Middle Aged
KW  - Neoplasm Grading
KW  - Neoplasm Recurrence, Local
KW  - Primary Cell Culture
KW  - Prognosis
KW  - Prostate
KW  - pathology
KW  - Prostate-Specific Antigen
KW  - Prostatectomy
KW  - Prostatic Neoplasms
KW  - Radiation Tolerance
KW  - Retinoid X Receptor alpha
KW  - Survival Rate
KW  - Time Factors
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2019.12.025
ER  -